A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Clinical trial NCT07662109 · RECRUITING
Trial details
- NCT number
- NCT07662109
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2028-07-05
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.